Original fundamental research starts and ENDS here.
BAC
21 filings
Timeline Columns Start Research 8-K Categories
2025
Q4 4 filings
Nov
Executive Officer Designations
4 officers removed from executive designation effective Dec 31, 2025
Oct
Q3 2025 Results
Financial data not available in provided content
Oct
Legal Opinion Filing
Legal opinion filed for Series P Notes and Series A Notes under existing S-3 shelf registration
Oct
Q3 Earnings
Net income $8.5B, EPS $1.06
Q3 7 filings
Sep
Co-Presidents Appointed
Dean Athanasia & James DeMare named Co-Presidents, Borthwick promoted to EVP
Sep
Executive Appointments - Co-Presidents Named
Dean Athanasia and James DeMare appointed Co-Presidents, Alastair Borthwick named EVP
Jul
Q2 2025 Results
Unable to extract - numerical data not available in provided excerpt
Jul
Preferred Stock Offering
2.5M depositary shares, 6.25% Series UU preferred stock, $25K liquidation preference
Jul
Stock Buyback & Dividend
$40B buyback program, $0.28 quarterly dividend
Jul
Q2 2025 Earnings
Net income $7.1B, EPS $0.89
Jul
Dividend Increase & CCAR Results
Dividend up to $0.28/share, CET1 ratio 11.8%
Q2 4 filings
Apr
Q1 2025 Results
Financial data not available in provided content
Apr
Preferred Stock Offering
3M depositary shares, Series OO 6.625% preferred stock
Apr
Annual Shareholder Meeting
Equity plan amended: +100M shares, director comp capped at $1M annually
Apr
Q1 2025 Earnings
Net income $7.4B, EPS $0.90
Q1 6 filings
Mar
2025 Proxy Statement
Annual meeting: Apr 22, 2025 virtual, $1 donation per voting account
Feb
Chief Accounting Officer Change
Johnbull Okpara appointed CAO, $600K salary + $5.4M incentive
Feb
FY 2024 Results
Financial metrics not clearly extractable from this XBRL format
📌 Unable to identify specific milestone from this technical filing data
Feb
CEO Compensation Approved
Moynihan 2024 total comp $35M vs $29M in 2023
Jan
Director Appointed
Maria N. Martinez appointed to Board and committees
Jan
Q4 2024 Earnings
Q4 net income $6.7B, EPS $0.82; FY net income $27.1B, EPS $3.21